This meta-analysis reviewed randomized controlled trials comparing suicide prevention interventions to usual care. It found that the WHO's Brief Intervention and Contact intervention was associated with significantly lower odds of death by suicide. Cognitive behavioral therapy and lithium also showed fewer suicide deaths among intervention groups, but results were not statistically significant. Overall, most psychosocial interventions and pharmacotherapies did not show clear evidence of reducing suicide risk. The study highlights the need for further research on effective prevention strategies.
A journal club article review prepared for the Psychiatry Residency of Texas Tech El Paso - Paper title: 'Psilocybin Produces Substantial & Sustained Decreases in Depression & Anxiety in Patients With Life-threatening Cancer: A Randomized Double-Blind Trial'
A journal club article review prepared for the Psychiatry Residency of Texas Tech El Paso - Paper title: 'Psilocybin Produces Substantial & Sustained Decreases in Depression & Anxiety in Patients With Life-threatening Cancer: A Randomized Double-Blind Trial'
Outcomes from 45 Years of Clinical Practice (Paul Clement)Scott Miller
Paul Clement is one of my heroes. He's been tracking the outcome of his clinical services for decades. I was stunned when, in 1994, he published results from his private work over a two decades long period. Now, we have the data from 45 years. Read it!
Title:
A Meta-Analysis of Adventure Therapy Outcomes and Moderators
Abstract:
This presentation reports on a meta-analytic review of 197 studies of adventure therapy participant outcomes (2,908 effect sizes, 206 unique samples). The short-term effect size for adventure therapy was moderate (g = .47) and larger than for alternative (.14) and no treatment (.08) comparison groups. There was little change during the lead-up (.09) and follow-up periods (.03) for adventure therapy, indicating long-term maintenance of the short-term gains. The short-term adventure therapy outcomes were significant for seven out of the eight outcome categories, with the strongest effects for clinical and self-concept measures, and the smallest effects for spirituality/morality. The only significant moderator of outcomes was a positive relationship with participant age.
References:
Bowen, D. J., & Neill, J. T. (2013). A meta-analysis of adventure therapy outcomes and moderators. The Open Psychology Journal, 6, 28-53. doi: 10.2174/1874350120130802001
Bowen, D. J., & Neill, J. T. (2013). A meta-analysis of adventure therapy outcomes and moderators: Pre-post adventure therapy age-based benchmarks for outcome categories. Retrieved from http://www.danielbowen.com.au/meta-analysis
For more information, see: http://www.danielbowen.com.au/meta-analysis
Article in Division 29's journal, psychotherapy that reviews the research on routine outcome monitoring, arguing that current efforts are at risk for repeating the history of failed efforts to improve the outcome of psychotherapy.
The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)Scott Miller
The April 2015 issue of the Carlat Psychiatry Report, an unbiased report/review of "all things psychiatric." The issue contains a lengthy interview with Dr. Scott Miller on the subject of top performing clinicians.
Để xem full tài liệu Xin vui long liên hệ page để được hỗ trợ
: https://www.facebook.com/thuvienluanvan01
HOẶC
https://www.facebook.com/garmentspace/
https://www.facebook.com/thuvienluanvan01
https://www.facebook.com/thuvienluanvan01
tai lieu tong hop, thu vien luan van, luan van tong hop, do an chuyen nganh
The folly of believing positive findings from underpowered intervention studiesJames Coyne
Presented at the European Health Psychology Conference, July 13, 2013, This slideshow shows the folly of accepting positive findings from underpowered studies. Much of the "evidence" in health psychology comes from such unreliable studies.
Suicides and suicide attempts during long term treatment with antidepressants...Daryl Chow
Abstract
Background: It is unclear whether antidepressants can pre- vent suicides or suicide attempts, particularly during long- term use. Methods: We carried out a comprehensive review of long-term studies of antidepressants (relapse prevention). Sources were obtained from 5 review articles and by search- es of MEDLINE, PubMed Central and a hand search of bibli- ographies. We meta-analyzed placebo-controlled antide- pressant RCTs of at least 3 months’ duration and calculated suicide and suicide attempt incidence rates, incidence rate ratios and Peto odds ratios (ORs). Results: Out of 807 studies screened 29 were included, covering 6,934 patients (5,529 patient-years). In total, 1.45 suicides and 2.76 suicide at- tempts per 1,000 patient-years were reported. Seven out of 8 suicides and 13 out of 14 suicide attempts occurred in an- tidepressant arms, resulting in incidence rate ratios of 5.03 (0.78–114.1; p = 0.102) for suicides and of 9.02 (1.58–193.6; p = 0.007) for suicide attempts. Peto ORs were 2.6 (0.6–11.2; nonsignificant) and 3.4 (1.1–11.0; p = 0.04), respectively. Dropouts due to unknown reasons were similar in the anti-
depressant and placebo arms (9.6 vs. 9.9%). The majority of suicides and suicide attempts originated from 1 study, ac- counting for a fifth of all patient-years in this meta-analysis. Leaving out this study resulted in a nonsignificant incidence rate ratio for suicide attempts of 3.83 (0.53–91.01). Conclu- sions: Therapists should be aware of the lack of proof from RCTs that antidepressants prevent suicides and suicide at- tempts. We cannot conclude with certainty whether antide- pressants increase the risk for suicide or suicide attempts. Researchers must report all suicides and suicide attempts in RCTs.
“Evidenced based” behavioral medicine as bad as bad pharmaJames Coyne
Introduction to symposium held at International Congress of Behavioral Medicine, Groningen, August 2014. Discusses the shortcomings of evidence-based behavioral medicine in light of efforts to reform the shortcomings of the Pharma literature.
Structured psychotherapies are treatments for mental health disorders that are recommended by international good practice guidelines. Their positive impact on the costs to healthcare funding bodies has been widely demonstrated. Nevertheless, in France today, psychotherapies delivered in private practice settings are not reimbursed to patients by health cover systems.
A financial evaluation of covering the cost of psychotherapies was performed using the methodology of the British programme Improving Access for Psychological Therapies (2005). The cost of a session was estimated at 41€, the reimbursement rate by the compulsory health insurance system at 70% and 60% for the care of individuals aged 18 to 75 presenting common, chronic and/or severe mental disorders.
The yearly cost for the cover of psychotherapeutic care was 514 million euros (between 308M and 347M€ for the compulsory systems) to treat 1.033M individuals in France, or 2.3% of the population.
In terms of the cost-benefit ratio, 1€ invested in psychotherapeutic treatment could, depending on patient profile, save from 1.14€ to 1.95€.
France has the 14 300 professionals qualified to deliver the psychotherapies required to treat this population.
With a view to providing appropriate care for patients, inter-professional collaboration among GPs and mental health professionals, and between clinical psychiatrists and psychologists, appears essential. These recommendations should be defined in national good practice guidelines.
A cancer diagnosis and cancer treatment can be traumatic. An experience with cancer can lead to serious psychological distress that should be addressed. In this webinar, Schuyler Cunningham, Clinical Social Worker, talks about what trauma is, how to identify it, and what steps to take next.
Outcomes from 45 Years of Clinical Practice (Paul Clement)Scott Miller
Paul Clement is one of my heroes. He's been tracking the outcome of his clinical services for decades. I was stunned when, in 1994, he published results from his private work over a two decades long period. Now, we have the data from 45 years. Read it!
Title:
A Meta-Analysis of Adventure Therapy Outcomes and Moderators
Abstract:
This presentation reports on a meta-analytic review of 197 studies of adventure therapy participant outcomes (2,908 effect sizes, 206 unique samples). The short-term effect size for adventure therapy was moderate (g = .47) and larger than for alternative (.14) and no treatment (.08) comparison groups. There was little change during the lead-up (.09) and follow-up periods (.03) for adventure therapy, indicating long-term maintenance of the short-term gains. The short-term adventure therapy outcomes were significant for seven out of the eight outcome categories, with the strongest effects for clinical and self-concept measures, and the smallest effects for spirituality/morality. The only significant moderator of outcomes was a positive relationship with participant age.
References:
Bowen, D. J., & Neill, J. T. (2013). A meta-analysis of adventure therapy outcomes and moderators. The Open Psychology Journal, 6, 28-53. doi: 10.2174/1874350120130802001
Bowen, D. J., & Neill, J. T. (2013). A meta-analysis of adventure therapy outcomes and moderators: Pre-post adventure therapy age-based benchmarks for outcome categories. Retrieved from http://www.danielbowen.com.au/meta-analysis
For more information, see: http://www.danielbowen.com.au/meta-analysis
Article in Division 29's journal, psychotherapy that reviews the research on routine outcome monitoring, arguing that current efforts are at risk for repeating the history of failed efforts to improve the outcome of psychotherapy.
The Carlat Psychiatry Report (Interview with Scott Miller, April 2015)Scott Miller
The April 2015 issue of the Carlat Psychiatry Report, an unbiased report/review of "all things psychiatric." The issue contains a lengthy interview with Dr. Scott Miller on the subject of top performing clinicians.
Để xem full tài liệu Xin vui long liên hệ page để được hỗ trợ
: https://www.facebook.com/thuvienluanvan01
HOẶC
https://www.facebook.com/garmentspace/
https://www.facebook.com/thuvienluanvan01
https://www.facebook.com/thuvienluanvan01
tai lieu tong hop, thu vien luan van, luan van tong hop, do an chuyen nganh
The folly of believing positive findings from underpowered intervention studiesJames Coyne
Presented at the European Health Psychology Conference, July 13, 2013, This slideshow shows the folly of accepting positive findings from underpowered studies. Much of the "evidence" in health psychology comes from such unreliable studies.
Suicides and suicide attempts during long term treatment with antidepressants...Daryl Chow
Abstract
Background: It is unclear whether antidepressants can pre- vent suicides or suicide attempts, particularly during long- term use. Methods: We carried out a comprehensive review of long-term studies of antidepressants (relapse prevention). Sources were obtained from 5 review articles and by search- es of MEDLINE, PubMed Central and a hand search of bibli- ographies. We meta-analyzed placebo-controlled antide- pressant RCTs of at least 3 months’ duration and calculated suicide and suicide attempt incidence rates, incidence rate ratios and Peto odds ratios (ORs). Results: Out of 807 studies screened 29 were included, covering 6,934 patients (5,529 patient-years). In total, 1.45 suicides and 2.76 suicide at- tempts per 1,000 patient-years were reported. Seven out of 8 suicides and 13 out of 14 suicide attempts occurred in an- tidepressant arms, resulting in incidence rate ratios of 5.03 (0.78–114.1; p = 0.102) for suicides and of 9.02 (1.58–193.6; p = 0.007) for suicide attempts. Peto ORs were 2.6 (0.6–11.2; nonsignificant) and 3.4 (1.1–11.0; p = 0.04), respectively. Dropouts due to unknown reasons were similar in the anti-
depressant and placebo arms (9.6 vs. 9.9%). The majority of suicides and suicide attempts originated from 1 study, ac- counting for a fifth of all patient-years in this meta-analysis. Leaving out this study resulted in a nonsignificant incidence rate ratio for suicide attempts of 3.83 (0.53–91.01). Conclu- sions: Therapists should be aware of the lack of proof from RCTs that antidepressants prevent suicides and suicide at- tempts. We cannot conclude with certainty whether antide- pressants increase the risk for suicide or suicide attempts. Researchers must report all suicides and suicide attempts in RCTs.
“Evidenced based” behavioral medicine as bad as bad pharmaJames Coyne
Introduction to symposium held at International Congress of Behavioral Medicine, Groningen, August 2014. Discusses the shortcomings of evidence-based behavioral medicine in light of efforts to reform the shortcomings of the Pharma literature.
Structured psychotherapies are treatments for mental health disorders that are recommended by international good practice guidelines. Their positive impact on the costs to healthcare funding bodies has been widely demonstrated. Nevertheless, in France today, psychotherapies delivered in private practice settings are not reimbursed to patients by health cover systems.
A financial evaluation of covering the cost of psychotherapies was performed using the methodology of the British programme Improving Access for Psychological Therapies (2005). The cost of a session was estimated at 41€, the reimbursement rate by the compulsory health insurance system at 70% and 60% for the care of individuals aged 18 to 75 presenting common, chronic and/or severe mental disorders.
The yearly cost for the cover of psychotherapeutic care was 514 million euros (between 308M and 347M€ for the compulsory systems) to treat 1.033M individuals in France, or 2.3% of the population.
In terms of the cost-benefit ratio, 1€ invested in psychotherapeutic treatment could, depending on patient profile, save from 1.14€ to 1.95€.
France has the 14 300 professionals qualified to deliver the psychotherapies required to treat this population.
With a view to providing appropriate care for patients, inter-professional collaboration among GPs and mental health professionals, and between clinical psychiatrists and psychologists, appears essential. These recommendations should be defined in national good practice guidelines.
A cancer diagnosis and cancer treatment can be traumatic. An experience with cancer can lead to serious psychological distress that should be addressed. In this webinar, Schuyler Cunningham, Clinical Social Worker, talks about what trauma is, how to identify it, and what steps to take next.
Understanding Psychosis and Schizophrenia Royal EdinburghJames Coyne
Offers evidence that group of UK clinical psychologists offer misinformation to persons seeking information about services for serious mental problems.
Protective factors against suicidal acts in major depression:Reasons for living, Journal Club Presentation in the Dept of Psychiatric Nursing, Kothamangalam
The Meaningful Assessment of Therapy OutcomesIncorporating .docxcherry686017
The Meaningful Assessment of Therapy Outcomes:
Incorporating a Qualitative Study Into a Randomized Controlled Trial
Evaluating the Treatment of Adolescent Depression
Nick Midgley
University College London and Anna Freud Centre, London,
United Kingdom
Flavia Ansaldo
Southwark Targeted Services—CAMHS, London,
United Kingdom
Mary Target
University College London
For many years, there have been heated debates about the best way to evaluate the efficacy and
effectiveness of psychological therapies. On the one hand, there are those who argue that the randomized
controlled trial (RCT) is the only reliable and scientifically credible way to assess psychological
interventions. On the other hand, there are those who have argued that psychological therapies cannot be
meaningfully assessed using a methodology developed to evaluate the impact of drug treatments, and that
the findings of RCTs lack “external validity” and are difficult to translate into routine clinical practice.
In this article, we advocate the use of mixed-method research designs for RCTs, combining the rigor of
quantitative data about patterns of change with the phenomenological contextualized insights that can be
derived from qualitative data. We argue that such an approach is especially important if we wish to
understand more fully the impact of therapeutic interventions within complex clinical settings. To
illustrate the value of a mixed-method approach, we describe a study currently underway in the United
Kingdom, in which a qualitative study (IMPACT-My Experience [IMPACT-ME]) has been “nested”
within an RCT (the Improving Mood With Psychoanalytic and Cognitive Behavioral Therapy [IMPACT]
study) designed to evaluate the effectiveness of psychological therapies in the treatment of adolescent
depression. We argue that such a mixed-methods approach can help us to evaluate the effectiveness of
psychological therapies and support the real-world implementation of our findings within increasingly
complex and multidisciplinary clinical contexts.
Keywords: adolescent depression, randomized controlled trials (RCTs), qualitative research, mixed-
methods design, outcome research
For many years, there have been heated debates about the best
way to evaluate the efficacy and effectiveness of psychological
therapies. On the one hand, there are those who argue that the
randomized controlled trial (RCT) (and meta-analyses of such
trials) is the only reliable and scientifically credible way to assess
psychological interventions. The RCT has long been considered
the “gold standard” approach, placed at the top of the “hierarchy of
evidence” and given almost exclusive credence by bodies such as
the Cochrane Collaboration and guideline developers such as the
National Institute for Health and Clinical Excellence (NICE). On
the other hand, there are those who have argued that psychological
therapies cannot be meaningfully assessed using a methodology
developed to evaluate the impact of drug treatme ...
1PAGE 21. What is the question the authors are asking .docxfelicidaddinwoodie
1
PAGE
2
1. What is the question the authors are asking?
They asked about a reduction in judgmental biases regarding the cost and probability associated with adverse social events as they are presumed as being mechanisms for the treatment of Social Anxiety Disorder (SAD). Also, the authors poised on the changes in judgmental biases as mechanisms to explain cognitive-behavioral therapy for social anxiety disorder. On top of that, they stated that methodological limitations extant studies highlight the possibility that rather than causing symptom relief, a significant reduction in judgmental biases tends to be consequences of it or correlate. Considerably, they expected cost bias at mid-treatment to be a predictor of the treatment outcome.
2. Why do the authors believe this question is important?
According to the authors, this question was relevant as methodological limitations of present studies reflect on the possibility that instead of causing symptom belief, a significant reduction in judgmental biases can be consequences or correlated to it. Additionally, they ought to ascertain the judgment bias between treated and non-treated participants. Significantly, this was important as they had to determine the impact of pre and post changes in cost and probability of the treatment outcomes. But, probability bias at mid-treatment was a predictor of the treatment outcome contrary to the cost bias at mid-treatment that could not be identified as a significant predictor of the treatment outcome.
3. How do they try to answer this question?
They conducted a study to evaluate the significant changes in judgmental bias as aspects of cognitive-behavioral therapy for social anxiety disorders. To do this, they conducted a study using information from two treatment studies; an uncontrolled trial observing amygdala activity as a response to VRE (Virtual Reality Exposure Therapy) with the use of functional magnetic resonance imaging and a randomized control trial that compared Virtual Reality Exposure Therapy with Exposure Group Therapy for SAD. A total of 86 individuals who met the DSM-IV-TR criteria for the diagnosis of non-generalized (n=46) and generalized (n=40) SAD participated. After completing eight weeks of the treatment protocol, the participants who identified public speaking as their most fearsome social situation were included. The SCID (Structured clinical interview for the DSM-IV) was used to ascertain diagnostic and eligibility status on Axis 1 conditions within substance abuse, mood and anxiety disorder modules. The social anxiety measures were measured with the use of BFNE (Brief Fear of Negative Evaluation), a self-reporting questioner that examined the degree to which persons fear to be assessed by other across different social settings. Additionally, the OPQ (Outcome Probability Questionnaire) self-reporting questionnaire was used to evaluate individual’s estimate on the probability that adverse, threatening events will occur at t ...
ABSTRACT- Background: The occurrence of psychiatric disorders is more in the prisoners than in general population. Co-morbidity is seen to be an important and complex entity in clinical assessment of mental state competence (diminished mental capacity, temporary insanity and insanity) in the offenders at the time of the offence. It has a great role in determining all possible options in future treatment of violent offenders. Aim: This research article is focused on the co-morbid psychiatric diagnoses and the treatment outcomes in the mentally ill prisoners referred to the tertiary care mental health facility. Materials and Method: Total 100 mentally ill prisoners referred to the tertiary care psychiatric hospital during the study period (Jan 2015 - Dec 2015) was the sample size. It was a prospective study and the sampling method was of the purposive type. Results: Besides their primary diagnosis, the referred prisoners had more than one co-morbid psychiatric diagnosis in 46% of the cases. The most frequent co-occurring conditions were learning disabilities, personality disorders, and substance use disorders. The outcomes for the psychiatric conditions were positive as patients responded well to the line of management. Conclusion: The study provides valuable data to understand the mental health needs and the treatment gaps in this population so as to plan adequate services to tackle these issues. Key-words- Mentally ill prisoners, Psychiatric co-morbidities, Treatment outcomes, Substance use disorders, Personality disorders
LRI05 - Self Help for Distress in Cancer - Is It Time For An RCT [Oct 2005]Alex J Mitchell
This is an academic presentation from 2005 outlining the case for a randomized controlled trial of a self-help programme to help people deal with distress and depression following the diagnosis of cancer
Organizational Contex and Patient Safety: Is there a Role for Mindfulness?Heather Gilmartin
Presentation to review and define the concept of organizational context, present research on context and the relationship to healthcare associated infections, review the practice of mindfulness, discuss a role of mindfulness in patient safety.
Nationwide assessment of mental wellbeing of frontline health workers in the ...Ahsan Aziz Sarkar
National Assessment of the Current Status of Mental Wellbeing of the Frontline Health Workers and Identifying the Needs for Additional Support in the Era of COVID-19 in Bangladesh
Identification, referral and rehabilitation of mentally ill persons in Bangla...Ahsan Aziz Sarkar
Presentation is in Bengali language. It discusses
Identification of mentally ill persons at the community level
Referral system of Bangladesh
Rehabilitation of mentally ill persons in Bangladesh
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
3. Source and publication details
British Journal of Psychiatry
June, 2017 issue
Volume number 210
Page 396-402
4. Authors
Natalie B. V. Riblet, MD, MPH
Yinong Young Xu, MS, DSc
Bradley Watts, MD, MPH
Geisel School of Medicine at Dartmouth USA
Brian shiner, MD, MPH;
The Dartmouth Institute for Health Policy and Clinical
Practice, Lebanon
5. Funding
This work was supported by the VA (Veterans Affairs)
National Center for Patient Safety Center of Inquiry
Program.
6. Background
Suicide is a significant public health concern.
10th leading cause of death and 3rd among 15-24
years age group
Suicide death is associated with considerable
emotional toll on family members.
7. Background
Suicide prevention strategies include
• Antidepressants
• Mood stabilizers and anti-psychotics
• Behavioral intervention
• Safer packaging and distribution of drugs
• Depression recognition, gatekeeper education,
lethal mean restriction
• Brief psychological intervention etc.
8. Aim of the study
To identify interventions for preventing suicide which
will help to take clinical decisions about suicide
prevention.
9. Research question
Among adults 18 years and older, which interventions
that are designed to prevent death by suicide (or
suicidal behavior or ideation) have greater efficacy
than usual care condition, placebo or waitlist at
preventing death by suicide?
10. Study design
A meta-analysis of randomized controlled trials (RCTs)
comparing the efficacy of various interventions versus
control to prevent death by suicide in adults.
11. Inclusion criteria
• Randomized controlled trials
• Study population age is 18 or more than 18
• Interventions targeted to prevent death by suicide
• Control group received usual care, placebo or
waitlist
• Outcome reported as death by suicide
• Studies conducted in English language
12. Search strategies
Medline (via Ovid), the Cochrane Library, PsycINFO,
Excerpta Medica Database (EMBASE) and The
Cumulative Index to Nursing and Allied Health
Literature (CINAHL)
Suicide, prevention, control, treatment and RCT were
common search terms.
14. Data analysis
Primary outcome is evaluated using the Peto method
and calculated as odds ratios (ORs) with 95%
confidence intervals and P-values.
Groupings for heterogeneity was assessed using
Cochrane’s Q and the I² statistic. Conventional
threshold of P<0.10 and I²>50% were used to indicate
statistical significance and meaningful heterogeneity
respectively.
15. Data analysis
Confirmatory analysis was done by Poisson regression
model with intervention effects.
A modified linear regression analysis (STATA) to
identify significant funnel plot asymmetry which
would indicate publication bias.
17. Results (Effects of complex
psychosocial interventions)
29 RCTs.
In the three trials of the WHO brief intervention and
contact (BIC) intervention, 3 out of 1041 patients in
the intervention group and 24 out of 987 patients in
the control group died by suicide.
The difference was significant (OR = 0.20, 95% CI 0.09–
0.42, P<0.0001)
18. Results in table
Complex psychosocial interventions
Intervention domain N IRR 95% CI
Total complex psychosocial
intervention
29 0.93 0.65-1.33
Intensive follow up program 11 0.71 0.34-1.48
Comprehensive follow up
program
5 0.30 0.07-1.22
Case management after
suicidal behavior
4 0.93 0.56-1.54
Case management for
psychosis
4 1.16 0.50-2.55
Letter /Phone contact 7 1.16 0.75-1.79
19. Results (Effects of psychotherapy)
A total of 24 RCTs.
In six trials of CBT for suicide prevention, 3 out of 514
patients in the intervention group and 10 out of 526
patients in the control group died by suicide.
The results, however, were not statistically significant
(OR = 0.34, 95% CI 0.12–1.03, P = 0.06; IRR = 0.30, 95%
CI 0.08–1.11, P= 0.07)
21. Results (Effects of pharmacotherapy)
14 RCTs on pharmacotherapy. (Lithium, Clozapine,
Anti-psychotics and Anti-depressants)
After accounting for random effects and length of
follow-up, there was no evidence among the pooled
trials that pharmacotherapy reduced the risk of
suicide (OR = 0.21, 95% CI 0.05–0.86; IRR = 0.10, 95%
CI 0.00–32.27)
23. Results (Other interventions)
Partial hospital admission (2 trials, n=432; OR=0.36,
95% CI 0.07–1.86, P>0.10).
Somatic therapies such as electroconvulsive therapy
(2 trials, n=92; OR=0.14, 95% CI 0.00–6.82, P>0.10).
24. Discussion (Summary of main result )
WHO’s BIC intervention associated with significantly
lower odds of death.
Lithium and CBT showed fewer deaths by suicide
among the intervention groups than the controls. But
authors were unable to draw any definitive
conclusions, as the confidence interval for the
summary estimates spanned no difference.
25. Discussion (Comparison with other
studies)
Other reviews have suggested that CBT for suicide
prevention may prevent suicidal behaviour in high-risk
populations. This study found that CBT-based
therapies were associated with lower odds of suicide,
but the results were not significant.
Unlike prior reviews, this study found no evidence
that problem-solving therapy or dialectical behaviour
therapy reduce the risk of suicide.
26. Discussion (Comparison with other
studies)
Consistent with others, this review found that most
psychosocial interventions were ineffective.
Unlike Mann et al and Zalsman et al this study found
that there was strong evidence that the WHO BIC
programme was associated with significantly lower
odds of suicide.
27. Discussion (Comparison with other
studies)
Zalsman et al reported that antidepressants reduced
the risk of suicide in adults, this article did not
replicate this finding.
Unlike previous reviews this review did not find that
lithium significantly reduced suicide.
Mann et al and Zalsman et al concluded that clozapine
has an anti-suicidal effect, this study could not
replicate this finding.
28. Discussion (Comparison with other
studies)
Many reviews stress the role of restricting access to
lethal methods in suicide prevention (Gun control,
Storage box for pesticides). This review was unable to
systematically study this type of intervention because
only one study met the inclusion criteria.
Zalsman et al concluded that other strategies such as
screening programs and media education have some
roles. This study was unable to assess these strategies
because no studies met the inclusion criteria.
29. Discussion (Meaning and implication)
The WHO BIC intervention was associated with
significantly lower odds of suicide, but is important to
test this strategy in other populations (developed
countries).
Findings do not suggest that lithium or CBT for suicide
prevention cause harm, but they also do not provide
clear evidence of effectiveness. Findings suggest the
need for further study of these interventions.
30. Strength of the study
Rigorous search of the literature.
Focus on death by suicide rather than suicidal plan,
attempt or self-harm which can be viewed as an
strength.
RCTs are the highest quality study design and the gold
standard for evaluating the efficacy of an
intervention.
50% of the articles come from research of last 10 yrs.
31. Weakness of the study
Owing to the small sample sizes, precision around the
summary estimate of the effect size, limited the
evaluation of some interventions.
Analysis did not include patient-level data, so unable
to explore potential moderators or mediators of the
efficacy of suicide prevention interventions.
RCTs are not ideal for rare outcome like death by
suicide.
32. Critical review…selection of the article
• Suicide is a global health problem.
• Article is a new one.
• This topic wasn’t discussed before.
• It is a systemic review. Comes from a credible
source.
• Intervention strategy (BIC) is important for low
resource country like Bangladesh.
• Further research can be done in our hospital facility.
33. Critical review…Source of article
Collected from British journal of psychiatry, it has
currently an impact factor of 7.06.
Article is cited 2 times.
35. Critical review…Title
Title fits the objective of the article; describes what is
the problem and how it is approached.
It is not unnecessarily long; related to the content of
the article.
36. Critical review…Methodology..Design..
Population..
• Systematic review of RCT is the highest quality
research.
• RCT is difficult to design for rare outcomes;
however best for intervention strategy.
• Articles are chosen following PRISMA guideline.
• Study population don’t contain population below
18.
• Patient characteristics are not included in the study.
38. Critical review…Biases
Publication bias was addressed and assessed by
Harbord’s modified test.
Sensitivity analysis was judged by the Cochrane Risk
of Bias Tool.
39. Critical review…Result
Result is consistent with the objective of the study
and answers research question. Result is statistically
expressed.
40. Critical review…What is missing
This article failed to point out which intervention is
good for which patient group.
Ignored child and adolescent suicide.
41. Home message
Brief Intervention and Contact (BIC) is good for low
resource countries. Government should put emphasis
on BIC training of primary health care workers.
This study contradicts some of the findings of few well
cited studies. So more research is needed in suicide
prevention strategies for the optimum clinical benefit
of patient groups.
42. Further Recommendations
• Suicide prevention strategies: a systematic review.
JAMA 2005; 294: 2064–74; Mann JJ et al.
• Suicide prevention strategies revisited: 10-year
systematic review. Lancet Psychiatry 2016; 3: 646–
59. Zalsman G et al.